Annual review 2022
2022 has been an excellent year for the PHG Foundation, not least because we have finally returned to business as usual at our offices in Cambridge, UK - whilst retaining the many benefits of digital connectivity. The team has produced some outstanding policy research and analysis, set out in our reports, briefings and other publications, and we have been pleased to undertake several fascinating pieces of commissioned work for national and international partners.
Towards the end of the year, we achieved a major milestone as we began our 25th year of operations since we were founded in 1997 as the Public Health Genetics Unit. A new book based on independent research into the history of genetics and genomics policy in the UK reveals what a very long way policy, health and genetics have come in this time - as has the PHG Foundation.
We look forward to celebrating this important anniversary with some major events for our stakeholders in early 2023, but this year has also been significant for me, marking ten years at PHG and five as Director.
In this time, I have been pleased to see our expertise, impact and reputation grow alongside our unceasing efforts to making science work for health. This mission remains as vital today as it was twenty-five years ago. Whilst genomic and related technologies and their medical applications have grown and continue to evolve, healthcare needs and challenges are also increasing.
As I prepare to hand over the leadership of our talented team to a new Director in the coming year, I am confident that PHG is well placed to identify and address the policy challenges of the years ahead and help ensure science and technology are used to the very best effect for health.
Dr Mark Kroese - Director